COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Substantial COVID-19 research investment has been allocated to randomized clinical trials
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
Association between caseload surge and COVID-19 survival in 558 US hospitals, March to August 2020
Background: Several US hospitals had surges in COVID-19 caseload, but their effect on
COVID-19 survival rates remains unclear, especially independent of temporal changes in …
COVID-19 survival rates remains unclear, especially independent of temporal changes in …
Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
Methodological quality of COVID-19 clinical research
The COVID-19 pandemic began in early 2020 with major health consequences. While a
need to disseminate information to the medical community and general public was …
need to disseminate information to the medical community and general public was …
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
No specific antiviral drugs have been approved for the treatment of COVID-19. This study
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Abstract Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …